Our data also indicate that serum RANKL/OPG ratios correlate with CTCs and that a low number of CTCs - even in the absence of a local breast cancer - is associated with a reduced serum RANKL/OPG ratio. This evidence concerns the gene TNFSF11 and breast carcinoma.